Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes

ClinicalTrials.gov ID: NCT01994642

Public ClinicalTrials.gov record NCT01994642. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel Design, Multiple-Site Study to Evaluate the Clinical Equivalence of Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspension (Par) Compared to CIPRODEX® (Ciprofloxacin 0.3%/Dexamethasone 0.1%) Sterile Otic Suspension (Alcon) in the Treatment of Acute Bacterial Otitis Media in Children With Patent Tympanostomy Tubes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to compare the relative efficacy and safety of the test formulation of ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension (Par) to the already-marketed formulation CIPRODEX® (ciprofloxacin 0.3%/dexamethasone 0.1%) sterile otic suspension (Alcon) in the treatment of acute bacterial otitis media in children with patent tympanostomy tubes.

Study identification

NCT ID
NCT01994642
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Par Pharmaceutical, Inc.
Industry
Enrollment
203 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Months to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2013
Primary completion
Feb 28, 2015
Completion
Feb 28, 2015
Last update posted
Sep 25, 2017

2013 – 2015

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Birmingham Pediatrics Birmingham Alabama 32505
Agave Clinical Ressearch Mesa Arizona 85202
Arizona Center for Clinical Trials Phoenix Arizona 85003
Visions Clinical Research, Tuscon Tucson Arizona 85712
Alliance Research Long Beach California 90813
San Marcus Research Clinic Miami Florida 33015
Florida Medical Center and Research Inc. Miami Florida 33142
South Miami Clinical Research Group Miami Florida 33142
Miami Dade Medical Resarch Institute Miami Florida 33176
Global Health Research Center Miami Lakes Florida 33016
Winter Park Clinical Research Winter Park Florida 32792
Research Integrity Owensboro Kentucky 42303
Dr. Craig Spiegel Bridgeton Missouri 63044
Dr. Scott Mathei Henderson Nevada 89704
Piedmont Ear Nose and Throat Associates, PA Winston-Salem North Carolina 27103
Accecss MD, Clinical Resarch Huber Heights Ohio 45424
Cyn3gry Gresham Oregon 97030
Rainbow Research, Inc Barnwell South Carolina 29812
Dr. John Ansley Orangeburg South Carolina 29118
Spartanburg and Greer ENT Spartanburg South Carolina 29303
PMG Research of Bristol Bristol Tennessee 37620
Eagle Family Medical Associates Crossville Tennessee 38555
The Education and Research Foundation, Inc Lynchburg Virginia 24501

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01994642, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2017 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01994642 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →